1. Home
  2. TWIN vs LCTX Comparison

TWIN vs LCTX Comparison

Compare TWIN & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$16.64

Market Cap

269.7M

Sector

Industrials

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.30

Market Cap

388.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWIN
LCTX
Founded
1918
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.7M
388.6M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
TWIN
LCTX
Price
$16.64
$1.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
65.5K
1.4M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
0.98%
N/A
EPS Growth
N/A
N/A
EPS
1.76
N/A
Revenue
$340,738,000.00
$14,556,000.00
Revenue This Year
$10.79
$109.40
Revenue Next Year
$8.43
N/A
P/E Ratio
$9.09
N/A
Revenue Growth
15.45
53.24
52 Week Low
$7.06
$0.64
52 Week High
$19.67
$2.09

Technical Indicators

Market Signals
Indicator
TWIN
LCTX
Relative Strength Index (RSI) 48.32 41.10
Support Level $14.38 $1.14
Resistance Level $18.95 $1.31
Average True Range (ATR) 1.24 0.08
MACD -0.20 0.00
Stochastic Oscillator 37.77 34.48

Price Performance

Historical Comparison
TWIN
LCTX

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: